Coexistence of Quasi-moyamoya Disease and POEMS Syndrome in a Patient with Intracranial Hemorrhage: A Case Report and Literature Review
- PMID: 28664017
- PMCID: PMC5364899
- DOI: 10.2176/nmccrj.cr.2016-0106
Coexistence of Quasi-moyamoya Disease and POEMS Syndrome in a Patient with Intracranial Hemorrhage: A Case Report and Literature Review
Abstract
POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome is a rare paraneoplastic syndrome elicited by plasma cell dyscrasia. Its clinical manifestations are multiple and stroke is not a recognized feature. A 44-year-old woman with a 3-month history of bilateral lower extremity sensorimotor disturbance was admitted to our hospital. Examinations revealed polyneuropathy, organomegaly, hypothyroidism, monoclonal gammopathy, pelvic plasmacytoma, and elevated serum vascular endothelial growth factor (VEGF) levels. A diagnosis of POEMS was made. Her condition was improved by radiation therapy of her pelvic plasmacytoma and she continued to be seen on an outpatient basis. Five years after her first admission she was re-admitted with sudden-onset right hemiparesis. A brain computed tomography (CT) scan revealed a left intracranial hemorrhage and magnetic resonance (MR) angiography and cerebral angiography showed occlusion of the proximal portion of the bilateral middle cerebral artery and narrowing of the bilateral internal carotid artery at the terminal portion; moyamoya vessels were seen. This is the first report of a patient whose intracranial hemorrhage was attributable to quasi-moyamoya disease associated with POEMS syndrome. We suggest that the POEMS syndrome be ruled out in the differential diagnosis of patients presenting with atypical stroke, multivessel stenotic lesions (moyamoya vessels), and polyneuropathy.
Keywords: POEMS syndrome; VEGF; quasi-moyamoya disease.
Conflict of interest statement
Conflicts of Interest Disclosure The authors declare no conflicts of interest.
Figures
References
-
- Dispenzieri A: POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management. Am J Hematol 89: 214– 223, 2014. - PubMed
-
- Miyamoto S, Yoshimoto T, Hashimoto N, Okada Y, Tsuji I, Tominaga T, Nakagawara J, Takahashi JC, JAM Trial Investigators : Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial. Stroke 45: 1415– 1421, 2014. - PubMed
-
- Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, Greipp PR, Witzig TE, Basu R, Suarez GA, Fonseca R, Lust JA, Gertz MA: POEMS syndrome: definitions and long-term outcome. Blood 101: 2496– 2506, 2003. - PubMed
-
- Lesprit P, Authier FJ, Gherardi R, Bélec L, Paris D, Melliere D, Schaeffer A, Godeau B: Acute arterial obliteration: a new feature of the POEMS syndrome? Medicine (Baltimore) 75: 226– 232, 1996. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources